| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
HealthSCOPE Benefits is committed to maintain the exclusive focus of managinghealthcare costs for client companies, to provide unsurpassed customer serviceand seamless benefits administration, managed care, and informatics servicesand to support client
Clinical Automated Office Solutions / CAOS is a Winston Salem, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Acclivity Healthcare is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pittsburgh Tissue Engineering Initiative is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.